Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA‐life study

Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA‐life study

Abstract Background Inflammation has been linked to prostate cancer and hypertension, but it remains equivocal whether elevated blood pressure (BP) influence prostate cancer risk and survival. Method Using Cox regression models, we examined the association between prediagnostic BP and prostate cance...

Full description

Bibliographic Details
Main Authors: Einar Stikbakke, Henrik Schirmer, Tore Knutsen, Martin Støyten, Tom Wilsgaard, Edward L. Giovannucci, Anne McTiernan, Anne E. Eggen, Hege S. Haugnes, Elin Richardsen, Inger Thune
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Cancer Medicine
Subjects:
hypertension
inflammation
mortality
prostate cancer
risk
Online Access:https://doi.org/10.1002/cam4.4523

Internet

https://doi.org/10.1002/cam4.4523

Similar Items